Recalls / Class II
Class IID-1520-2016
Product
Sennazon (sennosides) Syrup, 8.8 mg, 8 fl. oz. (237 mL) bottle, Mfd. for: Bayshore Pharmaceuticals, Tampla, FL 33619, NDC 76518-100-08.
- Affected lot / code info
- Lot #: 20391519, Exp 11/17
Why it was recalled
CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
Recalling firm
- Firm
- Pharmatech LLC
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 4131 Sw 47th Ave, Suite 1403, Davie, Florida 33314-4026
Distribution
- Quantity
- 1,008 bottles
- Distribution pattern
- Nationwide
Timeline
- Recall initiated
- 2016-08-08
- FDA classified
- 2016-09-27
- Posted by FDA
- 2016-10-05
- Terminated
- 2024-09-23
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-1520-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.